Deadline. Time periods. 

Deadline. 

‘‘(B) REVIEW.—Not later than 2 years after the date of the enactment of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 and every 6 years thereafter, the Secretary shall conduct a review of the elements described in subparagraph (A). Such review shall include a discussion of the addition of any elements pursuant to clause (v), including elements added to advancing new technologies, and identify any challenges in the incorporation of elements under subparagraph (A). The Secretary shall provide such review to the congres- sional committees of jurisdiction.’’; 

(II) by striking ‘‘and clinical laboratories’’ and inserting ‘‘, clinical laboratories, and public environmental health agencies’’; 

(iii) by striking ‘‘The network’’ and inserting the following: 

‘‘(A) IN GENERAL.—The network’’; and 

(iv) by adding at the end the following: 

(D) in paragraph (5)— 

(i) by redesignating subparagraphs (A) through (D) as clauses (i) through (iv), respectively, and adjusting the margins accordingly; 

(ii) by striking ‘‘In establishing’’ and inserting the following: 

‘‘(A) IN GENERAL.—In establishing’’; 

(iii) by adding at the end the following: 

‘‘(B) PUBLIC MEETING.— 

‘‘(i) IN GENERAL.—Not later than 180 days after the date of enactment of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, the Secretary shall convene a public meeting for pur- poses of discussing and providing input on the potential goals, functions, and uses of the network described in paragraph (1) and incorporating the elements described in paragraph (3)(A). 

‘‘(ii) EXPERTS.—The public meeting shall include representatives of relevant Federal agencies (including representatives from the Office of the National Coordi- nator for Health Information Technology and the National Institute of Standards and Technology); State, local, Tribal, and territorial public health officials; stakeholders with expertise in biosurveillance and situational awareness; stakeholders with expertise in capabilities relevant to biosurveillance and situational awareness, such as experts in informatics and data analytics (including experts in prediction, modeling, or forecasting); and other representatives as the Sec- retary determines appropriate. 

‘‘(iii) TOPICS.—Such public meeting shall include a discussion of— 

‘‘(I) data elements, including minimal or essen- tial data elements, that are voluntarily provided for such network, which may include elements from public health and public and private health care entities, to the extent practicable; 

‘‘(II) standards and implementation specifica- tions that may improve the collection, analysis, 

